Enterotoxin Vaccine Delivery System With Bioadherence. Phase 1.
Abstract
The primary of this Phase I program was to provide a stable peroral controlled delivery system for a vaccine which was designed to release its contents in the intestinal tract with or without an immunoadjuvant. A single administration of the vaccine must release at a rate sufficient for inoculation of the host immune system for up to six months. To insure sustained release in an environment as dynamic as the intestinal mucosa, adherence to the host tissue for several days is essential. Adhesion of this magnitude will require a delivery system configured with a bioadhesive polymer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 05, 1995
- Accession Number
- ADB212163
Entities
People
- Ronald P. Dues